TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 150 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2016. The put-call ratio across all filers is 2.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $69,000 | +885.7% | 120 | +100.0% | 0.00% | -50.0% |
| Q3 2016 | $7,000 | -22.2% | 60 | 0.0% | 0.00% | -33.3% |
| Q2 2016 | $9,000 | -76.3% | 60 | -76.9% | 0.00% | -76.9% |
| Q1 2016 | $38,000 | -11.6% | 260 | -7.1% | 0.01% | -18.8% |
| Q4 2015 | $43,000 | -88.3% | 280 | -89.1% | 0.02% | -87.2% |
| Q3 2015 | $369,000 | -10.9% | 2,580 | -10.4% | 0.12% | 0.0% |
| Q2 2015 | $414,000 | +9.5% | 2,880 | +7.5% | 0.12% | +28.9% |
| Q1 2015 | $378,000 | +29.0% | 2,680 | +35.4% | 0.10% | +27.6% |
| Q4 2014 | $293,000 | -12.5% | 1,980 | -9.2% | 0.08% | -28.3% |
| Q3 2014 | $335,000 | -14.1% | 2,180 | -21.6% | 0.11% | +19.1% |
| Q2 2014 | $390,000 | +14.0% | 2,780 | -9.7% | 0.09% | -7.3% |
| Q1 2014 | $342,000 | +4.9% | 3,080 | -6.7% | 0.10% | +1.1% |
| Q4 2013 | $326,000 | +10.1% | 3,300 | -15.4% | 0.10% | +8.0% |
| Q3 2013 | $296,000 | – | 3,900 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 565,951 | $24,483,000 | 8.44% |
| Murchinson Ltd. | 162,703 | $7,039,000 | 1.34% |
| Eversept Partners, LP | 220,286 | $9,529,572 | 0.73% |
| BRANDES INVESTMENT PARTNERS, LP | 379,322 | $16,410,000 | 0.35% |
| Analyst IMS Investment Management Services Ltd. | 17,657 | $764,000 | 0.07% |
| Claret Asset Management Corp | 7,279 | $315,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 326,427 | $14,086,000 | 0.06% |
| Renaissance Technologies | 678,300 | $29,343,000 | 0.03% |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 191,820 | $8,298,000 | 0.03% |
| ARK Investment Management | 55,566 | $2,404,000 | 0.01% |